Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-FR | Version v5-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2018-11-09 | 2018-11-09 |
| Drug Identification Number | 02256738 | 02256738 |
| Brand name | TIAZAC XC | TIAZAC XC |
| Common or Proper name | TIAZAC XC | TIAZAC XC |
| Company Name | BAUSCH HEALTH, CANADA INC. | BAUSCH HEALTH, CANADA INC. |
| Ingredients | DILTIAZEM HYDROCHLORIDE | DILTIAZEM HYDROCHLORIDE |
| Strength(s) | 120MG | 120MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL | ORAL |
| Packaging size | 90 | 90 |
| ATC code | C08DB | C08DB |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF | SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF |
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date | 2018-10-31 | 2018-10-31 |
| Actual start date | ||
| Estimated end date | ||
| Actual end date | 2018-11-07 | 2018-11-07 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |